Drug health responsibility at Johnson & Johnson


Shareholders are requesting the Board of Directors at Johnson & Johnson issue a report assessing the feasibility of adopting a policy of producer responsibility for disposal programs for unneeded or expired drugs and accessories.

This content is for signatories only. If you have a signatory account, please log in to view all collaboration content.